Shandong Pharmaceutical Glass Co Ltd (SHG:600529) — Market Cap & Net Worth
Market Cap & Net Worth: Shandong Pharmaceutical Glass Co Ltd (600529)
Shandong Pharmaceutical Glass Co Ltd (SHG:600529) has a market capitalization of $1.89 Billion (CN¥12.91 Billion) as of August 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #6335 globally and #1264 in its home market, demonstrating a -0.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Pharmaceutical Glass Co Ltd's stock price CN¥19.45 by its total outstanding shares 663614113 (663.61 Million). See 600529 capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Shandong Pharmaceutical Glass Co Ltd Market Cap History: 2015 to 2026
Shandong Pharmaceutical Glass Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $878.07 Million to $1.89 Billion (9.90% CAGR).
Shandong Pharmaceutical Glass Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Pharmaceutical Glass Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.43x
Shandong Pharmaceutical Glass Co Ltd's market cap is 0.43 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.81x
Shandong Pharmaceutical Glass Co Ltd's market cap is 2.81 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $975.15 Million | $2.06 Billion | $189.60 Million | 0.47x | 5.14x |
| 2017 | $1.03 Billion | $2.33 Billion | $262.76 Million | 0.44x | 3.90x |
| 2018 | $1.25 Billion | $2.58 Billion | $358.21 Million | 0.48x | 3.49x |
| 2019 | $2.59 Billion | $2.99 Billion | $458.69 Million | 0.86x | 5.64x |
| 2020 | $4.72 Billion | $3.43 Billion | $564.44 Million | 1.38x | 8.36x |
| 2021 | $4.17 Billion | $3.88 Billion | $591.09 Million | 1.08x | 7.05x |
| 2022 | $2.73 Billion | $4.19 Billion | $618.29 Million | 0.65x | 4.41x |
| 2023 | $2.49 Billion | $4.98 Billion | $775.80 Million | 0.50x | 3.20x |
| 2024 | $2.50 Billion | $5.13 Billion | $942.99 Million | 0.49x | 2.65x |
| 2025 | $1.94 Billion | $4.47 Billion | $689.63 Million | 0.43x | 2.81x |
Competitor Companies of 600529 by Market Capitalization
Companies near Shandong Pharmaceutical Glass Co Ltd in the global market cap rankings as of August 7, 2026.
Key companies related to Shandong Pharmaceutical Glass Co Ltd by market ranking:
- Smurfit WestRock plc (NYSE:SW): Ranked #1163 globally with a market cap of $22.44 Billion USD.
- Packaging Corp of America (NYSE:PKG): Ranked #1176 globally with a market cap of $22.16 Billion USD.
- Amcor Plc (AU:AMC): Ranked #1187 globally with a market cap of $21.86 Billion USD ( AU$30.89 Billion AUD).
- Amcor PLC (NYSE:AMCR): Ranked #1302 globally with a market cap of $19.64 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1163 | Smurfit WestRock plc | NYSE:SW | $22.44 Billion | $48.47 |
| #1176 | Packaging Corp of America | NYSE:PKG | $22.16 Billion | $256.01 |
| #1187 | Amcor Plc | AU:AMC | $21.86 Billion | AU$66.82 |
| #1302 | Amcor PLC | NYSE:AMCR | $19.64 Billion | $47.75 |
Shandong Pharmaceutical Glass Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shandong Pharmaceutical Glass Co Ltd's market cap moved from $878.07 Million to $ 1.89 Billion, with a yearly change of 9.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.89 Billion | -2.41% |
| 2025 | CN¥1.94 Billion | -22.66% |
| 2024 | CN¥2.50 Billion | +0.66% |
| 2023 | CN¥2.49 Billion | -8.86% |
| 2022 | CN¥2.73 Billion | -34.58% |
| 2021 | CN¥4.17 Billion | -11.62% |
| 2020 | CN¥4.72 Billion | +82.44% |
| 2019 | CN¥2.59 Billion | +106.63% |
| 2018 | CN¥1.25 Billion | +22.07% |
| 2017 | CN¥1.03 Billion | +5.13% |
| 2016 | CN¥975.15 Million | +11.06% |
| 2015 | CN¥878.07 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Shandong Pharmaceutical Glass Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.89 Billion USD |
| MoneyControl | $1.89 Billion USD |
| MarketWatch | $1.89 Billion USD |
| marketcap.company | $1.89 Billion USD |
| Reuters | $1.89 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more